Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Financial giants have made a conspicuous bullish move on Walgreens Boots Alliance. Our analysis of options history for ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
Walgreens, like other companies in the retail pharmacy space, has struggled with challenges related to low reimbursement and ...
These four dividend payers are poised to post solid fourth-quarter results and continue to provide way above-average passive ...
Stocktwits on MSN18h
Walgreens Stock Surges On Analyst Revisions After Strong Q1 Earnings: Retail Sentiment BrightensShares of Walgreens Boots Alliance ($WBA) have risen nearly 24% in the past five days as the pharmacy retailer gets price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback